Zobrazeno 1 - 4
of 4
pro vyhledávání: '"van Rijssel TI"'
Autor:
van Rijssel TI; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. t.i.vanrijssel@umcutrecht.nl., van Thiel GJMW; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., van Delden JJM; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
Health care analysis : HCA : journal of health philosophy and policy [Health Care Anal] 2024 May 19. Date of Electronic Publication: 2024 May 19.
Autor:
van Rijssel TI; University Medical Center Utrecht., van Thiel GJMW; University Medical Center Utrecht., Gardarsdottir H; University Medical Center Utrecht.; Utrecht University.; University of Iceland., van Delden JJM; University Medical Center Utrecht.
Publikováno v:
The American journal of bioethics : AJOB [Am J Bioeth] 2024 Jan 05, pp. 1-11. Date of Electronic Publication: 2024 Jan 05.
Autor:
van Rijssel TI; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: t.i.vanrijssel@umcutrecht.nl., de Jong AJ; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Santa-Ana-Tellez Y; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Boeckhout M; Med Law Consultancy Foundation, The Hague, The Netherlands., Zuidgeest MGP; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., van Thiel GJMW; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
Drug discovery today [Drug Discov Today] 2022 Oct; Vol. 27 (10), pp. 103326. Date of Electronic Publication: 2022 Jul 20.
Autor:
de Jong AJ; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., van Rijssel TI; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Zuidgeest MGP; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., van Thiel GJMW; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Askin S; Regulatory Affairs Innovation, Novartis Pharma AG, Basel, Switzerland., Fons-Martínez J; The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., De Smedt T; Global Regulatory Affairs, UCB Pharma, Brussels, Belgium., de Boer A; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Santa-Ana-Tellez Y; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Aug; Vol. 112 (2), pp. 344-352. Date of Electronic Publication: 2022 May 17.